Keywords
Accelerated Progression
glomerular filtration rate
Risk Factors
Public Health
Prevention
How to Cite
Abstract
Background: Chronic Kidney Disease (CKD) is a global public health problem with increasing prevalence and a substantial burden on healthcare systems. The characteristics of rapid progressors and factors that may predict accelerated CKD progression require further exploration, especially since there are no published studies about this topic in Colombia.
Purpose: To identify the clinical and sociodemographic factors associated with the rapid progression of CKD in a large cohort of Colombian patients.
Methods: This retrospective observational study included two cohorts of G1 to G4 stage CKD patients without dialysis from the Colombian North Coast. Follow-up was conducted for 18 months (n=14,420) and 24 months (n=10,042). Patients were divided into rapid progressors and stable progressors based on the glomerular filtration rate (GFR) slope <?5 mL/min/1.73m2/year or ?-5 mL/min/1.73 m2/year, respectively.
Results: 37.68% of the cohort was classified as rapid progressors at 24 months and 28.41% at 18 months. An R2=0.77 was found in both cohorts for GFR measurements, indicating a linear trend toward loss. Furthermore, accelerated progression was observed in younger patients and those with higher diastolic blood pressure values. Conclusion: In two large cohorts of renal patients, approximately 4 out of 10 patients were classified as rapid progressors at 24 months of follow-up and 3 out of 10 at 18 months of follow-up. It is important to identify patients at higher risk of accelerated CKD progression in the short term to provide them with personalized and effective care.
References
Hosseinpoor AR, Bergen N, Kunst A, Harper S, Guthold R, Rekve D, et al. Socioeconomic inequalities in risk factors for non communicable diseases in low-income and middle-income countries: results from the World Health Survey. BMC Public Health. 2012;12:912. https://doi.org/10.1186/1471-2458-12-912
Gheorghe A, Griffiths U, Murphy A, Legido-Quigley H, Lamptey P, Perel P. The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review. BMC Public Health. 2018 ag. 6;18(1). https://doi.org/10.1186/s12889-018-5806-x
Herrera-Añazco P, Taype-Rondan A, Lazo-Porras M, Alberto Quintanilla E, Ortiz-Soriano VM, Hernandez AV. Prevalence of chronic kidney disease in Peruvian primary care setting. BMC Nephrol. 2017 dic. 19;18(1):246. https://doi.org/10.1186/s12882-017-0655-x
Acuña L, Sánchez P, Soler LA, Alvis LF. Kidney disease in Colombia: Priority for risk management. Rev Panam Salud Púb. 2016 ag.;40(1):16-22. http://www.ncbi.nlm.nih.gov/pubmed/27706391
Ameh OI, Ekrikpo UE, Kengne AP. Preventing CKD in Low- and Middle-Income Countries: A Call for Urgent Action. Kidney Int Reports. 2020 mzo.;5(3):255-62. https://doi.org/10.1016/j.ekir.2019.12.013
Cuenta de Alto Costo. Situación de la enfermedad renal crónica la hipertensión arterial y diabetes mellitus en Colombia 2019. Cuenta de Alto Costo. https://cuentadealtocosto.org/site/download/situacion-de-la-enfermedad-renal-cronica-la-hipertension-arterial-y-diabetes-mellitus-en-colombia-2019/
Nugent RA, Fathima SF, Feigl AB, Chyung D. The Burden of Chronic Kidney Disease on Developing Nations: A 21st Century Challenge in Global Health. Nephron Clin Pract. 2011;118(3):c269-77. https://doi.org/10.1159/000321382
Sarmiento-Bejarano H, Ramírez-Ramírez C, Carrasquilla-Sotomayor M, Alvis-Zakzuk NJ, Alvis-Guzmán N. Carga económica de la enfermedad renal crónica en Colombia, 2015-2016. Rev Salud Uninorte. 2019;35:84-100. https://doi.org/10.14482/sun.35.1.616.6
Vesga JI, Cepeda E, Pardo CE, Paez S, Sanchez R, Sanabria RM. Chronic Kidney Disease Progression and Transition Probabilities in a Large Preventive Cohort in Colombia. Int J Nephrol. 2021 mzo. 31;2021:1-9. https://doi.org/10.1155/2021/8866446
Go AS, Yang J, Tan TC, Cabrera CS, Stefansson BV, Greasley PJ, et al. Contemporary rates and predictors of fast progression of chronic kidney disease in adults with and without diabetes mellitus. BMC Nephrol. 2018 dic. 22;19(1):146. https://doi.org/10.1186/s12882-018-0942-1
Ali I, Chinnadurai R, Ibrahim ST, Green D, Kalra PA. Predictive factors of rapid linear renal progression and mortality in patients with chronic kidney disease. BMC Nephrol. 2020 dic. 14;21(1):345. https://doi.org/10.1186/s12882-020-01982-8
Tótoli C, Carvalho AB, Ammirati AL, Draibe SA, Canziani ME. Associated factors related to chronic kidney disease progression in elderly patients. PLoS One. 2019 jul. 23;14(7):e0219956. https://doi.org/10.1371/journal.pone.0219956
Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, et al. Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease. Ann Intern Med. 2013 ag.;159(4):233. https://doi.org/10.7326/0003-4819-159-4-201308200-00004
de Goeij MC, Voormolen N, Halbesma N, de Jager DJ, Boeschoten EW, Sijpkens YW, et al. Association of blood pressure with decline in renal function and time until the start of renal replacement therapy in pre-dialysis patients: a cohort study. BMC Nephrol. 2011 dic.;12(1):38. https://doi.org/10.1186/1471-2369-12-38
Levin A, Djurdjev O, Beaulieu M, Er L. Variability and Risk Factors for Kidney Disease Progression and Death Following Attainment of Stage 4 CKD in a Referred Cohort. Am J Kidney Dis. 2008 oct.;52(4):661-71. https://doi.org/10.1053/j.ajkd.2008.06.023
Arora P, Jalal K, Gupta A, Carter RL, Lohr JW. Progression of kidney disease in elderly stage 3 and 4 chronic kidney disease patients. Int Urol Nephrol. 2017 jun.;49(6):1033-40. https://doi.org/10.1007/s11255-017-1543-9
Baek SD, Baek CH, Kim JS, Kim SM, Kim JH, Kim SB. Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study. Scand J Urol Nephrol. 2012 jun.;46(3):232-8. https://doi.org/10.3109/00365599.2011.649045
Marks A, Fluck N, Prescott GJ, Robertson LM, Simpson WG, Smith WC, et al. Definitions of progression in chronic kidney disease--predictors and relationship to renal replacement therapy in a population cohort with a 6 year follow-up. Nephrol Dial Transplant. 2014 febr.;29(2):333-41. https://doi.org/10.1093/ndt/gft393
Shojamoradi MH, Saberi Isfeedvajani M, Mahdavi-Mazdeh M, Ahmadi F, Gatmiri SM, Abbasi Larki R. Chronic kidney disease progression in elderly Iranian patients: a cohort study. Nephrourol Mon. 2014 sept.;6(5):e20748. https://doi.org/10.5812/numonthly.20748
O’Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007 oct.;18(10):2758-65. https://doi.org/10.1681/ASN.2007040422
Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA, et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int. 2006 jun.;69(12):2155-61. https://doi.org/10.1038/sj.ki.5000270
Bazyluk A, Malyszko J, Zbroch E. Cardiovascular risk in chronic kidney disease: what is new in the pathogenesis and treatment? Postgrad Med. 2018 jul.;130(5):461-9. https://doi.org/10.1080/00325481.2018.1481714
Ali I, Chinnadurai R, Ibrahim ST, Kalra PA. Adverse outcomes associated with rapid linear and non-linear patterns of chronic kidney disease progression. BMC Nephrol. 2021 dic. 6;22(1):82. https://doi.org/10.1186/s12882-021-02282-5
Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, et al. Longitudinal Progression Trajectory of GFR Among Patients With CKD. Am J Kidney Dis. 2012 abr.;59(4):504-12. https://doi.org/10.1053/j.ajkd.2011.12.009
Abeysekera RA, Healy HG, Wang Z, Cameron AL, Hoy WE. Heterogeneity in patterns of progression of chronic kidney disease. Intern Med J. 2021 febr.;51(2):220-8. https://doi.org/10.1111/imj.14770
Zacharias HU, Altenbuchinger M, Schultheiss UT, Raffler J, Kotsis F, Ghasemi S, et al. A Predictive Model for Progression of CKD to Kidney Failure Based on Routine Laboratory Tests. Am J Kidney Dis. 2022 febr.;79(2):217-230.e1. https://doi.org/10.1053/j.ajkd.2021.05.018
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.